GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Rel | rn6_v1_chr14_-_108509892_108509892 | 0.79 | 1.1e-70 | Click! |
Nfkb1 | rn6_v1_chr2_-_240866689_240866689 | 0.65 | 1.5e-39 | Click! |
Rela | rn6_v1_chr1_+_220992770_220992770 | 0.39 | 5.2e-13 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_163049084 Show fit | 214.19 |
ENSRNOT00000091644
|
Cd69 molecule |
|
chr18_+_56071478 Show fit | 163.29 |
ENSRNOT00000025344
ENSRNOT00000025354 |
CD74 molecule |
|
chr20_-_1878126 Show fit | 160.23 |
ENSRNOT00000000995
|
ubiquitin D |
|
chr4_+_69384145 Show fit | 143.51 |
ENSRNOT00000084834
|
T cell receptor beta, variable 13-2 |
|
chr10_-_85947938 Show fit | 142.42 |
ENSRNOT00000037318
ENSRNOT00000082427 |
ADP-ribosylation factor like GTPase 5C |
|
chr20_-_4863198 Show fit | 138.91 |
ENSRNOT00000001108
|
lymphotoxin beta |
|
chr20_+_5184515 Show fit | 134.41 |
ENSRNOT00000089411
|
lymphotoxin-beta |
|
chr20_-_4863011 Show fit | 134.24 |
ENSRNOT00000079503
|
lymphotoxin beta |
|
chr13_+_112031594 Show fit | 113.96 |
ENSRNOT00000008440
|
laminin subunit beta 3 |
|
chr1_+_266053002 Show fit | 106.99 |
ENSRNOT00000026235
|
nuclear factor kappa B subunit 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 420.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
19.5 | 234.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
4.2 | 175.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
32.7 | 163.3 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
20.0 | 160.2 | GO:0070842 | aggresome assembly(GO:0070842) |
3.2 | 158.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
19.2 | 134.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
12.0 | 131.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
31.2 | 124.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
6.8 | 115.7 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 671.5 | GO:0005615 | extracellular space(GO:0005615) |
2.0 | 618.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
30.3 | 272.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 202.8 | GO:0005654 | nucleoplasm(GO:0005654) |
54.4 | 163.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
2.8 | 137.0 | GO:0016235 | aggresome(GO:0016235) |
12.7 | 114.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
7.1 | 105.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 103.7 | GO:0005925 | focal adhesion(GO:0005925) |
6.1 | 98.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
61.5 | 307.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.9 | 275.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.7 | 229.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
5.1 | 212.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
4.2 | 173.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
9.3 | 166.5 | GO:0070628 | proteasome binding(GO:0070628) |
11.7 | 164.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
27.2 | 163.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
18.1 | 163.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
14.4 | 129.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 409.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
8.8 | 291.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
3.7 | 148.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
3.3 | 141.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
3.6 | 132.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
6.7 | 114.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
3.2 | 100.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
8.4 | 92.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.3 | 82.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
3.1 | 82.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.7 | 686.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
11.3 | 191.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.5 | 130.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
2.3 | 114.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
3.8 | 107.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
2.8 | 96.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
4.0 | 88.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.0 | 81.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 60.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
3.3 | 60.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |